{
    "clinical_study": {
        "@rank": "68905", 
        "arm_group": {
            "arm_group_label": "almond", 
            "arm_group_type": "Experimental", 
            "description": "almonds are substituted for visible fat and carbohydrates"
        }, 
        "brief_summary": {
            "textblock": "This prospective cohort study of an almond-enriched diet (within the overall context of\n      Asian Indian dietary guidelines) was conducted to test the hypothesis that in patients with\n      T2DM almond-enriched balanced diet improves glycemic measures and CVD risk factors."
        }, 
        "brief_title": "Almond Intervention in Type 2 Diabetes Mellitus", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Cardiovascular Diseases", 
        "condition_browse": {
            "mesh_term": [
                "Cardiovascular Diseases", 
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients in the age range of 25-65 years\n\n          -  on stable doses of metformin from past 3 months\n\n          -  having HbA1C less than 9%\n\n          -  LDL-c \u2265100 mg/dl were recruited\n\n        Exclusion Criteria:\n\n          -  Patients on insulin therapy, plioglitazone, insulin secretagogues, beta blockers or\n             steroids or suffering from diabetes for more than 10 years\n\n          -  having high uric acid levels (\u2265 8 mg/dl),\n\n          -  with accelerated hypertension (stage 2 hypertension according to JNC guidelines) ,\n             hypothyroidism, suffering from acute infection or any debilitating disease or with\n             renal failure,\n\n          -  appreciable weight loss (more than 10%) during past 6 months\n\n          -  Patients with known food allergy, lipid altering medication or extraneous factors\n             that can affect glycemic or lipid parameters"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02027740", 
            "org_study_id": "almond.2013"
        }, 
        "intervention": {
            "arm_group_label": "almond", 
            "intervention_name": "almond", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Delhi", 
                    "country": "India"
                }, 
                "name": "Fortis Flt Lt Hospital"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effect of Almond Supplementation on Glycemic and Cardiovascular Risk Factors in Asian Indians in North India With Type 2 Diabetes Mellitus: A 24-week Prospective Cohort Study", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in LDL-c", 
            "safety_issue": "No", 
            "time_frame": "baseline, after six months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02027740"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Diabetes Foundation, India", 
            "investigator_full_name": "Dr Anoop Misra", 
            "investigator_title": "Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "HbA1C", 
            "safety_issue": "No", 
            "time_frame": "baseline, after six months of intervention"
        }, 
        "source": "Diabetes Foundation, India", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Diabetes Foundation, India", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2009", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}